IMS Health raises $1.3B in NY IPO

IMS Health raises $1.3 billion in its New York IPO.
IMS Health raises $1.3 billion in its New York IPO.

IMS Health raised $1.3 billion last month in its New York IPO. The company, which analysts expected would see shares go for between $18 and $21, sold 65 million shares at $20, according to

Formerly public, IMS went private in 2010, after TPG Capital, Canada Pension Plan Investment Board (CPPIB) and Leonard Green & Partners bought it for $5.2 billion, including debt. After the offering, TPG's stake was set to be cut 50% from 62.2%, without underwriters exercising their full option.

The Danbury, CT-based company said it plans to use the offering's net proceeds for debt financing and general corporate purposes.

IMS's operating income rose to $276 million in the nine months ended September 30, 2013, from $173 million a year earlier. Revenue rose 4% to $1.9 billion.

You must be a registered member of MMM to post a comment.

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters